News
-
-
COMMUNIQUÉ DE PRESSE
Silver X Mining Corp. Announces Significant Increase In Mineral Resource Estimate For The Nueva Recuperada Project, Including Additional High-Grade Resource At The Plata Mining Unit
Silver X Mining Corp. announces updated mineral resource estimate for Nueva Recuperada Property in Peru, showing significant growth in resources, particularly in Plata Mining Unit. Technical Report under NI 43-101 standards -
COMMUNIQUÉ DE PRESSE
Alset AI Completes Majority Acquisition of AI Cloud Computing Company Cedarcross Technologies
Alset AI Ventures Inc. strengthens AI infrastructure leadership by acquiring a 26% equity stake in Cedarcross International Technologies Inc., reinforcing commitment to high-performance computing solutions -
-
COMMUNIQUÉ DE PRESSE
Kalo Gold Confirms Extensive Epithermal Gold System At Aurum Prime With 25 High-Priority Targets Identified
Kalo Gold Corp. announces 25 high-priority gold targets in Aurum Epithermal Field at Vatu Aurum Project, Fiji. Significant advancements in exploration efforts with new geological model established. Multi-phase 2025 drill program planned -
-
COMMUNIQUÉ DE PRESSE
EON Resources Inc. Announces Completion of Preliminary Assessment Which Could Potentially Yield Up to 20 Million Untapped Barrels of Oil via Horizonal Drilling in the Lower Intervals of the San Andres Formation
EON Resources Inc. completes preliminary assessment of oil and gas potential in Permian Basin's Grayburg-Jackson Field, expecting significant new drilling locations -
COMMUNIQUÉ DE PRESSE
Interactive Strength Inc. (Nasdaq:TRNR) Launches FAQ's About Acquisition, Business Strategy and $50M Pro Forma 2025 Guidance
Interactive Strength Inc. encourages shareholders to sign up for direct email updates and shares information on recent acquisition agreement and updated revenue guidance for 2025 -
-
COMMUNIQUÉ DE PRESSE
Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April
